Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.

Abstract

AKA and APF appear to be linked markers of an immunological process which, in RF positive subjects, predicts the development of clinical arthritis. However, disease manifestations develop in only a proportion of cases.